The Report Guru

According to the new market research report Defibrillators Market is projected to reach USD 10.88 Billion by 2022 from USD 9.32 Billion in 2017, growing at a CAGR of 3.1%. Factors such as technological advancements in defibrillators, rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training & awareness programs on defibrillators are expected to propel the growth of this market. Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=549   As of 2016, some of the prominent players in the defibrillators market were Medtronic (Ireland), St. Jude Medical (US), Boston Scientific (US), Philips (Netherlands), ZOLL Medical (US), BIOTRONIK (Germany), Physio-Control (US), Cardiac Science (US), LivaNova (UK), Nihon Kohden (Japan), SCHILLER (Switzerland), Mindray Medical (China), Mediana (South Korea), METRAX (Germany), and METsis (Turkey). Analysis of the market developments between 2014 and 2017 show that pro...

According to research report the global vascular imaging market is expected to reach USD 5.95 billion by 2022 from USD 4.35 billion in 2017, at a CAGR of 6.5%. The report covers imaging procedures used to assess blood flow for the effective diagnosis and treatment of various cardiovascular diseases (CVDs). Growing incidence and prevalence of cardiovascular diseases, growing aging population, and technological innovations has led to the wide application of vascular imaging, thus driving the growth of the market. Speak to Analyst : https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=247188200   The vascular imaging market is consolidated in nature due to the presence of large players. The key players in this market are Siemens Healthineers (Germany), GE Healthcare (U.K.), Toshiba Medical Systems Corporation (Japan), Hitachi Medical Corporation (Japan), Samsung Medison (South Korea), Shimadzu Corp. (Japan), St. Jude Medical, Inc. (U.S.), TERUMO Corporation (Japan), Ko...

According to research report the Elastography Imaging Market is expected to grow from USD 2.5 billion in 2018 to USD 4.6 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 11.0% during the forecast period. The major driving factors in the elastography imaging market are growing incidence of breast cancer and chronic liver diseases, and a rising preference for minimally invasive procedures across the globe. Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=107232051 The ultrasound elastography imaging segment is expected to account largest share in the global elastography imaging market during the year 2018. On the basis of modality, the elastography imaging market is segmented into ultrasound and magnetic resonance. Ultrasound imaging involves the imaging of organs by exposing the anatomy to high-frequency sound waves. Elasticity imaging or elastography through ultrasound elastography (USE) provides complementary information to convention...

According to research report the report Disposable Medical Device Sensors Market is poised to reach USD 5,936 Million by 2020, growing at a CAGR of 10.3% during the forecast period of 2015 to 2020.This report studies the Disposable Medical Device Sensors market over the forecast period of 2015 to 2020. Disposable medical device sensors are emerging as powerful, cost-effective tools for diagnosing diseases, monitoring vital human parameters, and for various therapeutic applications. Over the years, sensor-based devices have evolved in terms of characteristics, performance, and features due to the continuous improvements in sophistication of electronics in medical and pharmaceutical applications. The advent of IT revolution, wireless sensor technology, disposable sensors, and biosensors in healthcare has played a significant role in the evolution of sensors in healthcare. Moreover, the advent of microsystem technologies such as MEMS, SI-based sensors, and microfluidic chips has revo...

According to the new market research report  IVD Quality Control Market is poised to reach USD 1.04 Billion by 2022, at a CAGR of 3.5% from 2017 to 2022. The growth in the IVD quality controls market is mainly driven by the growing number of accredited laboratories and increasing mandates on the use of quality controls from regulatory and accreditation bodies. Similarly, the rise in adoption of third-party controls is also driving the overall growth of the IVD quality controls market. The additional costs involved in the quality control process, budget constraints in hospitals & laboratories, and the unfavorable reimbursement scenario for IVD tests are the major factors restraining the growth of the IVD quality controls market. Speak to Analyst : https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=198032582 In this report, the IVD quality controls market is segmented on the basis of product and service, application, manufacturer type, end user, and region. On t...

According to research report the global cancer biomarkers market is projected to reach USD 20.48 billion by 2022 from USD 11.53 billion in 2017, at a CAGR of 12.2%. Factors such as the rising prevalence of cancer, increasing government support for research in cancer biomarkers, increasing use of biomarkers in the drug discovery and development process, and increasing use of biomarker tests for diagnostic purposes are fueling the growth of this market. However, an unfavorable regulatory and reimbursement scenario and the high capital investments required for biomarker development and validation are some factors expected to restrain the market. In this report, the market is segmented into biomarker type, cancer type, profiling technology, application, and region. The cancer biomarkers market on the basis of cancer type is classified into breast, lung, colorectal, prostate, melanoma, leukemia, thyroid, bladder, non-hodgkin’s lymphoma, kidney, and other cancers including multiple myel...

According to the new market research " Pacemakers Market  by Implant ability (External), Technology (Single Chamber, Dual Chamber, CRT-P/Biventricular Pacemaker), Type (Conventional, MRI Compatible), End User (Hospitals and Cardiac Centres, Ambulatory Surgical Center) - Global Forecast to 2023", The pacemakers market is projected to reach USD 4.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 2.0%. Growth in this market is driven by increasing prevalence of cardiovascular diseases and technological advancements in devices. The implantable pacemakers segment, by implant ability, projected to occupy the majority of the market share and grow at the fastest rate during the forecast period. The implantable pacemakers segment is projected to be the fastest-growing segment, by implant ability, during the forecast period. The large share of the implantable pacemakers segment is primarily attributed to the increasing prevalence of CVDs and the rising preference for these ...